Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

28 Nov 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated November 28, 2022, titled ‘Zydus receives tentative approval from the USFDA for Levothyroxine Sodium for Injection’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1376.00
Cipla 1417.00
Lupin 2021.00
Zydus Lifesciences 1190.10
View more..